Advertisement
Canada markets closed
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7323
    -0.0000 (-0.01%)
     
  • CRUDE OIL

    83.84
    +0.27 (+0.32%)
     
  • Bitcoin CAD

    88,001.82
    +290.71 (+0.33%)
     
  • CMC Crypto 200

    1,392.48
    +9.91 (+0.72%)
     
  • GOLD FUTURES

    2,346.70
    +4.20 (+0.18%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,771.75
    +204.25 (+1.16%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,791.70
    +163.22 (+0.43%)
     
  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

How Is Arrowhead Pharmaceuticals Stock Positioned?

How Is Arrowhead Pharmaceuticals Stock Positioned?

When the market opened in 2018, Arrowhead Pharmaceuticals stock was selling at $3.69. Cantor Fitzgerald has raised its target price for Arrowhead Pharmaceuticals to $24 from $18. In July, Chardan Capital raised its price target to $24.50 from $17.50.